Cargando…

MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease

Replication-restricted modified vaccinia virus Ankara (MVA) is a licensed smallpox vaccine and numerous clinical studies investigating recombinant MVAs (rMVAs) as vectors for prevention of other infectious diseases have been completed or are in progress. Two rMVA COVID-19 vaccine trials are at an in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ruikang, Americo, Jeffrey L., Cotter, Catherine A., Earl, Patricia L., Erez, Noam, Peng, Chen, Moss, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805450/ https://www.ncbi.nlm.nih.gov/pubmed/33442693 http://dx.doi.org/10.1101/2020.12.30.424878

Ejemplares similares

One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection
por: Liu, Ruikang, et al.
Publicado: (2021)

Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection
por: Americo, Jeffrey L., et al.
Publicado: (2022)

SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells
por: Liu, Ruikang, et al.
Publicado: (2019)

DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge
por: Nigam, Pragati, et al.
Publicado: (2007)

Interferon α/β Decoy Receptor Encoded by a Variant in the Dryvax Smallpox Vaccine Contributes to Virulence and Correlates with Severe Vaccine Side Effects
por: Liu, Ruikang, et al.
Publicado: (2022)

Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses
por: Earl, Patricia L., et al.
Publicado: (2020)

Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines
por: Meseda, Clement A., et al.
Publicado: (2016)

Comparative live bioluminescence imaging of monkeypox virus dissemination in a wild-derived inbred mouse (Mus musculus castaneus) and outbred African dormouse (Graphiurus kelleni)
por: Earl, Patricia L., et al.
Publicado: (2015)

Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice
por: Cotter, Catherine A., et al.
Publicado: (2023)

Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins
por: Wyatt, Linda S., et al.
Publicado: (2017)

Elimination of A-type inclusion formation enhances cowpox virus replication in mice: Implications for orthopoxvirus evolution
por: Kastenmayer, Robin J., et al.
Publicado: (2014)

Pre-existing humoral immunity in military smallpox vaccinees temporally effects MVA-vectored transgene expression in dendritic cells
por: Ngauy, V, et al.
Publicado: (2012)

Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells
por: Peng, Chen, et al.
Publicado: (2020)

MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
por: López-Gil, Elena, et al.
Publicado: (2020)

Heterologous Prime-Boost Regimens Using rAd35 and rMVA Vectors Elicit Stronger Cellular Immune Responses to HIV Proteins Than Homologous Regimens
por: Ratto-Kim, Silvia, et al.
Publicado: (2012)

Assessing Bacterial Populations in the Lung by Replicate Analysis of Samples from the Upper and Lower Respiratory Tracts
por: Charlson, Emily S., et al.
Publicado: (2012)

Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the Lung
por: Förster, Reinhold, et al.
Publicado: (2020)

Genetic studies of the susceptibility of classical and wild-derived inbred mouse strains to monkeypox virus
por: Earl, Patricia L., et al.
Publicado: (2015)

Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model
por: Americo, Jeffrey L., et al.
Publicado: (2023)

A novel genotype of MVA that efficiently replicates in single cell suspensions
por: Jordan, Ingo, et al.
Publicado: (2013)

Susceptibility of the wild-derived inbred CAST/Ei mouse to infection by orthopoxviruses analyzed by live bioluminescence imaging
por: Americo, Jeffrey L., et al.
Publicado: (2014)

A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination
por: Huang, Xiaoxing, et al.
Publicado: (2009)

Synchronous melanosis of upper and lower urinary tract
por: Alzubaidi, Ahmad N., et al.
Publicado: (2022)

Development of Eczema Vaccinatum in Atopic Mouse Models and Efficacy of MVA Vaccination against Lethal Poxviral Infection
por: Knitlova, Jarmila, et al.
Publicado: (2014)

An Ad/MVA vectored Theileria parva antigen induces schizont-specific CD8(+) central memory T cells and confers partial protection against a lethal challenge
por: Svitek, Nicholas, et al.
Publicado: (2018)

Primary Malignant Melanoma of the Genitourinary Tract with Upper and Lower Tracts Involvement
por: Sutton, Broderick, et al.
Publicado: (2013)

P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
por: Robinson, HL, et al.
Publicado: (2009)

Transgene Expression and Host Cell Responses to Replication-Defective, Single-Cycle, and Replication-Competent Adenovirus Vectors
por: Crosby, Catherine M., et al.
Publicado: (2017)

Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies Analysis
por: Rueca, Martina, et al.
Publicado: (2020)

Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract
por: Hui, Kenrie P.Y., et al.
Publicado: (2022)

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine
por: Shen, Xiaoying, et al.
Publicado: (2017)

Clinical Aspects of Upper and Lower Respiratory Tract Infections
por: Grossman, Ronald F.
Publicado: (2012)

Bacterial topography of the upper and lower respiratory tract in pigs
por: Pirolo, Mattia, et al.
Publicado: (2023)

GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
por: Robinson, H, et al.
Publicado: (2012)

A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice
por: Weger-Lucarelli, James, et al.
Publicado: (2014)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
por: Green, C, et al.
Publicado: (2023)

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
por: Tscherne, Alina, et al.
Publicado: (2021)

The 90 MVA transformer
Publicado: (1974)

Approximating Vector Scheduling: Almost Matching Upper and Lower Bounds
por: Bansal, Nikhil, et al.
Publicado: (2016)

Diagnosis of influenza from lower respiratory tract sampling after negative upper respiratory tract sampling
por: Bogoch, Isaac I., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0g022eb5k7bv10doelmprbialq